CNR2 and Down syndrome: Finally, it is important to emphasize how the two endocannabinoids, AEA and 2-AG, which are derived from arachidonic acid and activate the metabolic syndrome exacerbating receptor CB1, but also the anti-inflammatory receptor CB2 [15], were not significantly increased by the MedDiet interventions.